If you need more lookups,
subscriptions start at $34 USD/month.
Chris Fox Location
Chicago, IL, US
Chris Fox Work
2023 -now Executive Vice President US Commercial, Head of Innovative Franchise @
2021 -2023 President, Novartis Gene Therapies @
2020 -2021 Vice President and US General Manager - Cardiometabolic, Bone and Nephrology @
2018 -2020 Vice President and General Manager, United Kingdom and Ireland @
2015 -2018 Vice President of Sales @
2015 -2015 Business Unit Head - Orthopedics @
2014 -2014 Principal @ Fox Consulting, LLC
2012 -2013 Senior Vice President, SagePath Medical @ SagePath Medical LLC
1999 -2012 VP of Sales, VP of Operations, VP of Business Insights, Sr. Dir. of Marketing @
1997 -1999 Market Development Manager @
1991 -1997 Area Business Manager @
Chris Fox Education
University of Wisconsin-Whitewater
Bachelor of Administration (Marketing)
Chris Fox Skills
Sales Management
Hospitals
Sales Force Effectiveness
Pharmaceutical Sales
Product Launch
Pharmaceutical Industry
Cardiology
Managed Care
Endocrinology
Sales Operations
Strategy
Neurology
Business Insights
Marketing
Marketing Strategy
Project Management
Management
Urology
Orthopedics
Biologics
Rheumatology
Nephrology
Gastroenterology
Respiratory Products
Integration
Team Building
Business Development
Business Intelligence
New Business Development
Salesforce Training
Leadership
Sales
Operations
Training
Business Strategy
Customer Service
Public Speaking
Chris Fox Summary
Chris Fox, based in Chicago, IL, US, is currently a Executive Vice President US Commercial, Head of Innovative Franchise at Teva Pharmaceuticals. Chris Fox brings experience from previous roles at Novartis Gene Therapies and Amgen. Chris Fox holds a Bachelor of Administration in Marketing @ University of Wisconsin-Whitewater. With a robust skill set that includes Sales Management, Hospitals, Sales Force Effectiveness, Pharmaceutical Sales, Product Launch and more. Chris Fox has 4 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Chris Fox?
Find contact details for 700 million professionals.